STANLEY A. PLOTKIN, M.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

DYNAVAX TECHNOLOGIES CORP

Filing Date Source Excerpt
2012-04-25 Stanley A. Plotkin, M.D. 79 Director ... The following table shows for the fiscal year ended December 31, 2011 certain information with respect to the compensation of all non-employee directors of the Company: Stanley A. Plotkin, M.D. $36,500 $22,846 $59,346
2013-04-29 Stanley A. Plotkin, M.D. 80 Director ... The following table shows for the fiscal year ended December 31, 2012, certain information with respect to the compensation of all non-employee directors of the Company: Stanley A. Plotkin, M.D. Fees Earned or Paid in Cash $44,000 Options and Awards Granted $183,419 Total $227,419 ... Our Nominating and Governance Committee is composed of two directors: Drs. Kisner (Chairperson) and Cano.
2014-04-28 Stanley A. Plotkin, M.D. 81 Director ... The following table shows for the fiscal year ended December 31, 2013, certain information with respect to the compensation of all non-employee directors of the Company: Stanley A. Plotkin, M.D. Fees Earned or Paid in Cash $40,000 Options and Awards Granted $44,625 Total $84,625
2015-04-21 Stanley A. Plotkin, M.D. 82 Director ... Dr. Plotkin has been a member of our Board since August 2005. ... The following table shows for the fiscal year ended December 31, 2014, certain information with respect to the compensation of all non-employee directors of the Company: Stanley A. Plotkin, M.D. $40,000 fees earned or paid in cash, $22,901 options and awards, total $62,901.
2016-04-22 Stanley A. Plotkin, M.D. 83 Director ... The following table shows for the fiscal year ended December 31, 2015, certain information with respect to the compensation of all non-employee directors of the Company: Stanley A. Plotkin, M.D. $40,000 Fees Earned or Paid in Cash, $151,751 Option Awards, $191,751 Total.
2017-04-21 Stanley A. Plotkin, M.D. 84 Director ... Our Board has determined that the following directors are independent directors within the meaning of the applicable NASDAQ listing standards: Ms. Phillips, Ms. Brege and Mr. Ricciardi as well as Drs. Carson, Cano, Kisner, Oronsky and Plotkin ... The following table shows for the fiscal year ended December 31, 2016, certain information with respect to the compensation of all non-employee directors of the Company: Stanley A. Plotkin, M.D. $40,000 Fees Earned or Paid in Cash, $70,692 Option Awards, $110,692 Total.
2017-07-10 Stanley A. Plotkin, M.D., Director

Data sourced from SEC filings. Last updated: 2026-03-05